336 related articles for article (PubMed ID: 28359293)
1. Memory performance-related dynamic brain connectivity indicates pathological burden and genetic risk for Alzheimer's disease.
Quevenco FC; Preti MG; van Bergen JM; Hua J; Wyss M; Li X; Schreiner SJ; Steininger SC; Meyer R; Meier IB; Brickman AM; Leh SE; Gietl AF; Buck A; Nitsch RM; Pruessmann KP; van Zijl PC; Hock C; Van De Ville D; Unschuld PG
Alzheimers Res Ther; 2017 Mar; 9(1):24. PubMed ID: 28359293
[TBL] [Abstract][Full Text] [Related]
2. Recognition memory is associated with altered resting-state functional connectivity in people at genetic risk for Alzheimer's disease.
Matura S; Prvulovic D; Butz M; Hartmann D; Sepanski B; Linnemann K; Oertel-Knöchel V; Karakaya T; Fußer F; Pantel J; van de Ven V
Eur J Neurosci; 2014 Oct; 40(7):3128-35. PubMed ID: 24989884
[TBL] [Abstract][Full Text] [Related]
3. Association of Brain Amyloid-β With Slow Gait in Elderly Individuals Without Dementia: Influence of Cognition and Apolipoprotein E ε4 Genotype.
Nadkarni NK; Perera S; Snitz BE; Mathis CA; Price J; Williamson JD; DeKosky ST; Klunk WE; Lopez OL
JAMA Neurol; 2017 Jan; 74(1):82-90. PubMed ID: 27842173
[TBL] [Abstract][Full Text] [Related]
4. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E ε4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease.
Wang X; Wang J; He Y; Li H; Yuan H; Evans A; Yu X; He Y; Wang H
J Alzheimers Dis; 2015; 45(3):781-95. PubMed ID: 25624419
[TBL] [Abstract][Full Text] [Related]
6. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
[TBL] [Abstract][Full Text] [Related]
7. Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden.
Zwan MD; Villemagne VL; Doré V; Buckley R; Bourgeat P; Veljanoski R; Salvado O; Williams R; Margison L; Rembach A; Macaulay SL; Martins R; Ames D; van der Flier WM; Ellis KA; Scheltens P; Masters CL; Rowe CC
J Alzheimers Dis; 2016; 49(4):1115-22. PubMed ID: 26639956
[TBL] [Abstract][Full Text] [Related]
8. Beta-amyloid associated differential effects of APOE ε4 on brain metabolism in cognitively normal elderly.
Yi D; Lee DY; Sohn BK; Choe YM; Seo EH; Byun MS; Woo JI
Am J Geriatr Psychiatry; 2014 Oct; 22(10):961-70. PubMed ID: 24495404
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E ε4 modulates functional brain connectome in Alzheimer's disease.
Wang J; Wang X; He Y; Yu X; Wang H; He Y
Hum Brain Mapp; 2015 May; 36(5):1828-46. PubMed ID: 25619771
[TBL] [Abstract][Full Text] [Related]
10. The TT allele of rs405509 synergizes with APOE ε4 in the impairment of cognition and its underlying default mode network in non-demented elderly.
Ma C; Zhang Y; Li X; Chen Y; Zhang J; Liu Z; Chen K; Zhang Z
Curr Alzheimer Res; 2016; 13(6):708-17. PubMed ID: 26825091
[TBL] [Abstract][Full Text] [Related]
11. Modulation on brain gray matter activity and white matter integrity by APOE ε4 risk gene in cognitively intact elderly: A multimodal neuroimaging study.
Cai S; Jiang Y; Wang Y; Wu X; Ren J; Lee MS; Lee S; Huang L
Behav Brain Res; 2017 Mar; 322(Pt A):100-109. PubMed ID: 28108320
[TBL] [Abstract][Full Text] [Related]
12. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
Oh H; Madison C; Baker S; Rabinovici G; Jagust W
Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
[TBL] [Abstract][Full Text] [Related]
13. APOE ε4 moderates amyloid-related memory decline in preclinical Alzheimer's disease.
Lim YY; Villemagne VL; Pietrzak RH; Ames D; Ellis KA; Harrington K; Snyder PJ; Martins RN; Masters CL; Rowe CC; Maruff P;
Neurobiol Aging; 2015 Mar; 36(3):1239-44. PubMed ID: 25559335
[TBL] [Abstract][Full Text] [Related]
14. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
[TBL] [Abstract][Full Text] [Related]
15. Rhinal hypometabolism on FDG PET in healthy APO-E4 carriers: impact on memory function and metabolic networks.
Didic M; Felician O; Gour N; Bernard R; Pécheux C; Mundler O; Ceccaldi M; Guedj E
Eur J Nucl Med Mol Imaging; 2015 Sep; 42(10):1512-21. PubMed ID: 25900275
[TBL] [Abstract][Full Text] [Related]
16. Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment.
Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
J Korean Med Sci; 2016 Feb; 31(2):286-95. PubMed ID: 26839485
[TBL] [Abstract][Full Text] [Related]
17. Enhanced resting-state functional connectivity between core memory-task activation peaks is associated with memory impairment in MCI.
Zhang Y; Simon-Vermot L; Araque Caballero MÁ; Gesierich B; Taylor ANW; Duering M; Dichgans M; Ewers M;
Neurobiol Aging; 2016 Sep; 45():43-49. PubMed ID: 27459924
[TBL] [Abstract][Full Text] [Related]
18. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
[TBL] [Abstract][Full Text] [Related]
19. Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment.
van Bergen JM; Li X; Hua J; Schreiner SJ; Steininger SC; Quevenco FC; Wyss M; Gietl AF; Treyer V; Leh SE; Buck F; Nitsch RM; Pruessmann KP; van Zijl PC; Hock C; Unschuld PG
Sci Rep; 2016 Oct; 6():35514. PubMed ID: 27748454
[TBL] [Abstract][Full Text] [Related]
20. Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease.
Voevodskaya O; Sundgren PC; Strandberg O; Zetterberg H; Minthon L; Blennow K; Wahlund LO; Westman E; Hansson O;
Neurology; 2016 May; 86(19):1754-61. PubMed ID: 27164711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
